198 related articles for article (PubMed ID: 32686834)
1. Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus.
Tan BK; Chalouni M; Ceron DS; Cinaud A; Esterle L; Loko MA; Katlama C; Poizot-Martin I; Neau D; Chas J; Morlat P; Rosenthal E; Lacombe K; Naqvi A; Barange K; Bouchaud O; Gervais A; Lascoux-Combe C; Garipuy D; Alric L; Goujard C; Miailhes P; Aumaitre H; Duvivier C; Simon A; Lopez-Zaragoza JL; Zucman D; Raffi F; Lazaro E; Rey D; Piroth L; Boué F; Gilbert C; Bani-Sadr F; Dabis F; Sogni' P; Wittkop L; Boccara F;
Clin Infect Dis; 2021 May; 72(9):e215-e223. PubMed ID: 32686834
[TBL] [Abstract][Full Text] [Related]
2. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.
Chew KW; Bhattacharya D; Horwich TB; Yan P; McGinnis KA; Tseng C; Freiberg MS; Currier JS; Butt AA
J Viral Hepat; 2017 Oct; 24(10):814-822. PubMed ID: 28273386
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort].
Michel L; Lions C; Winnock M; Lang JP; Loko MA; Rosenthal E; Marchou B; Valantin MA; Morlat P; Roux P; Sogni P; Spire B; Poizot-Martin I; Lacombe K; Lascoux-Combe C; Duvivier C; Neau D; Dabis F; Salmon-Ceron D; Carrieri MP;
HIV Med; 2016 Nov; 17(10):758-765. PubMed ID: 27187027
[TBL] [Abstract][Full Text] [Related]
4. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals.
Gillis J; Smieja M; Cescon A; Rourke SB; Burchell AN; Cooper C; Raboud JM;
Antivir Ther; 2014; 19(3):309-17. PubMed ID: 24429380
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of and factors associated with hepatic steatosis in patients coinfected with hepatitis C virus and HIV: Agence Nationale pour la Recherche contre le SIDA et les hépatites virales CO3 Aquitaine Cohort.
Neau D; Winnock M; Castéra L; Bail BL; Loko MA; Géraut L; Dupon M; Ragnaud JM; Lacoste D; Lafon ME; Bioulac-Sage P; Dabis F;
J Acquir Immune Defic Syndr; 2007 Jun; 45(2):168-73. PubMed ID: 17527092
[TBL] [Abstract][Full Text] [Related]
6. All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort.
Sogni P; Gilbert C; Lacombe K; Piroth L; Rosenthal E; Miailhes P; Gervais A; Esterle L; Chas J; Poizot-Martin I; Dominguez S; Simon A; Morlat P; Neau D; Zucman D; Bouchaud O; Lascoux-Combe C; Bani-Sadr F; Alric L; Goujard C; Vittecoq D; Billaud E; Aumaître H; Boué F; Valantin MA; Dabis F; Salmon D; Wittkop L
Clin Infect Dis; 2016 Sep; 63(6):763-770. PubMed ID: 27317796
[TBL] [Abstract][Full Text] [Related]
7. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
Merchante N; Rivero-Juárez A; Téllez F; Merino D; José Ríos-Villegas M; Márquez-Solero M; Omar M; Macías J; Camacho A; Pérez-Pérez M; Gómez-Mateos J; Rivero A; Antonio Pineda J;
Hepatology; 2012 Jul; 56(1):228-38. PubMed ID: 22278746
[TBL] [Abstract][Full Text] [Related]
8. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.
Erqou S; Papaila A; Halladay C; Ge A; Liu MA; Jiang L; Lally M; Menon A; Shah NR; Miech E; Virani SS; Zullo AR; Shireman TI; Longenecker CT; Ross D; Sullivan JL; Wu WC; Rudolph JL
Am Heart J; 2022 Jul; 249():12-22. PubMed ID: 35318028
[TBL] [Abstract][Full Text] [Related]
9. Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
Nahon P; Bourcier V; Layese R; Audureau E; Cagnot C; Marcellin P; Guyader D; Fontaine H; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Leroy V; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Dharancy S; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Benhamou Y; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Zucman D; Di Martino V; Thibaut V; Salmon D; Ziol M; Sutton A; Pol S; Roudot-Thoraval F;
Gastroenterology; 2017 Jan; 152(1):142-156.e2. PubMed ID: 27641509
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients.
Fernández-Montero JV; Barreiro P; de Mendoza C; Labarga P; Soriano V
J Viral Hepat; 2016 Jan; 23(1):47-52. PubMed ID: 26390144
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment.
Mocroft A; Lundgren J; Gerstoft J; Rasmussen LD; Bhagani S; Aho I; Pradier C; Bogner JR; Mussini C; Uberti Foppa C; Maltez F; Laguno M; Wandeler G; Falconer K; Trofimova T; Borodulina E; Jevtovic D; Bakowska E; Kase K; Kyselyova G; Haubrich R; Rockstroh JK; Peters L;
Clin Infect Dis; 2020 May; 70(10):2131-2140. PubMed ID: 31504296
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models.
Krikke M; Hoogeveen RC; Hoepelman AI; Visseren FL; Arends JE
HIV Med; 2016 Apr; 17(4):289-97. PubMed ID: 26268806
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
Triant VA; Perez J; Regan S; Massaro JM; Meigs JB; Grinspoon SK; D'Agostino RB
Circulation; 2018 May; 137(21):2203-2214. PubMed ID: 29444987
[TBL] [Abstract][Full Text] [Related]
14. Association of human immunodeficiency virus and hepatitis C virus infection with long-term outcomes post-ST segment elevation myocardial infarction in a disadvantaged urban community.
Shitole SG; Kuniholm MH; Hanna DB; Boucher T; Peng AY; Berardi C; Shah T; Bortnick AE; Christia P; Scheuer J; Kizer JR
Atherosclerosis; 2020 Oct; 311():60-66. PubMed ID: 32947199
[TBL] [Abstract][Full Text] [Related]
15. HIV/HCV coinfection and the risk of cardiovascular disease: A meta-analysis.
Osibogun O; Ogunmoroti O; Michos ED; Spatz ES; Olubajo B; Nasir K; Madhivanan P; Maziak W
J Viral Hepat; 2017 Nov; 24(11):998-1004. PubMed ID: 28502092
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Incidence of Human Papillomavirus Infection in Men Having Sex With Men Enrolled in a Pre-exposure Prophylaxis Study: A Sub-study of the Agence Nationale de Recherches sur le SIDA et les Hépatites Virales "Intervention Préventive de l'Exposition aux Risques avec et pour les hommes Gays" Trial.
Cotte L; Veyer D; Charreau I; Péré H; Cua E; Carette D; Chas J; Capitant C; Chidiac C; Fléjou JF; Fouéré S; Heard I; Meyer L; Puech J; Tremblay C; Delaugerre C; Molina JM
Clin Infect Dis; 2021 Jan; 72(1):41-49. PubMed ID: 31907521
[TBL] [Abstract][Full Text] [Related]
17. Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort.
Bruyand M; Thiébaut R; Lawson-Ayayi S; Joly P; Sasco AJ; Mercié P; Pellegrin JL; Neau D; Dabis F; Morlat P; Chêne G; Bonnet F;
Clin Infect Dis; 2009 Oct; 49(7):1109-16. PubMed ID: 19705973
[TBL] [Abstract][Full Text] [Related]
18. Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children.
Rouet F; Chaix ML; Inwoley A; Anaky MF; Fassinou P; Kpozehouen A; Rouzioux C; Blanche S; Msellati P;
Clin Infect Dis; 2008 Feb; 46(3):361-6. PubMed ID: 18171303
[TBL] [Abstract][Full Text] [Related]
19. Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response.
Bani-Sadr F; Loko MA; Pambrun E; Winnock M; Carrieri P; Gilbert C; Duvivier C; Bouchaud O; Gervais A; Dabis F; Salmon D;
AIDS; 2014 May; 28(8):1155-60. PubMed ID: 24499953
[TBL] [Abstract][Full Text] [Related]
20. Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women.
Kelly EM; Dodge JL; Sarkar M; French AL; Tien PC; Glesby MJ; Golub ET; Augenbraun M; Plankey M; Peters MG
Clin Infect Dis; 2016 Aug; 63(4):512-8. PubMed ID: 27225241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
